{
    "id": "mda",
    "name": { "ja": "MDA", "en": "MDA" },
    "IUPAC_name": "1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine",
    "aliases": [
        "Tenamfetamine",
        "methylenedioxyamphetamine",
        "メチレンジオキシアンフェタミン",
        "3,4-メチレンジオキシアンフェタミン",
        "3,4-Methylenedioxyamphetamine",
        "Sass",
        "Sassafras",
        "Ecstasy",
        "エクスタシー",
        "XTC",
        "罰"],
    "identifier": {
        "pubchem_cid": "1614",
        "inchi_key": "ZKSRYGGYHFXCAG-UHFFFAOYSA-N"
    },
    "categories": ["エンタクトジェン", "サイケデリック", "中枢神経刺激薬"],
    "legal": {
        "jp": {
            "key": "mdma"
        }
    },
    "summary": "低用量ではエンタクトジェンとして高用量では幻覚剤として作用するアンフェタミン誘導体",
    "effects": {
        "effects_positive": [
            "共感・愛情の増加",
            "感覚の強化",
            "エネルギー増加",
            "社交性の向上"
        ],
        "effects_negative": [
            "不安・パニック",
            "顎の緊張・歯ぎしり",
            "吐き気",
            "不眠"
        ]},
    "external_resources": {
        "experiences": {
            "label": "Erowid: MDA Experience Vault",
            "url": "https://www.erowid.org/experiences/subs/exp_MDA.shtml"
        },
        "dosage_duration": {
            "label": "TripSit: MDMA",
            "url": "https://tripsit.me/factsheets/mda"
        }
    }

}
